Understanding depression. Volume 1, Biomedical and neurobiological background /
Saved in:
Imprint: | Singapore : Springer, [2018] |
---|---|
Description: | 1 online resource |
Language: | English |
Subject: | |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11543021 |
Table of Contents:
- 1. Genetic and epigenetic aspects of depression
- 1-1. Highlights on pharmacogenetics and pharmacogenomics in depression
- 1-2. Imaging genetics studies on susceptibility genes for major depressive disorder: the present and the future
- 1-3. Gene-environmental interaction and role of epigenetic in depression
- 1-4. The role of microRNAs and long noncoding RNAs in depression: diagnosis and therapeutic implication
- 1-5. The role of early life stress in HPA axis and depression
- 2. Molecular-, cellular-level aspects of depression
- 2-1.Complex role of serotonin receptors in depression
- 2-2. Emerging role of glutamate receptors in pathophysiology of depression
- 2-3. New perspective on mTOR pathways: a new target of depression
- 2-4. Cellular aging in depression: the role of telomere-telomerase system
- 2-5. Differentiation and biological markers in subtype of depression
- 3. Neural circuit-level aspect of depression
- 3-1. Molecular, structural, and functional neuroimaging in depression
- 3-2. Resting-state activity in depression; a link to spatiotemporal psychopathology
- 3-3. Functional neuroimaging in depression: a tool to predict treatment outcome and response
- 3-4. Cortical-subcortical interactions in the pathophysiology of depression
- 3-5. Pathophysiology and treatment strategies for different types of depression
- 3-6. The effect of neurostimulation in depression
- 4. Multicellular system-level aspect of depression
- 4-1. Inflammation, depression and neurodegeneration: a possible cause of dementia in late life depression?
- 4-2. Gut-microbiota-brain axis and depression
- 4-3. The interactions of immune inflammation and oxidative and nitrosative stress with the kynurenine and melatonergic pathways in depression
- 4-4. Glia-neuron cross-talk in depression
- 4-5. Depression model in primate: relevance to novel drug discovery
- 5. Species-, individual-, gender-, culture-specific aspects of depression
- 5-1. Precision psychiatry: personalized clinical approach to depression
- 5-2. Gender differences in depression
- 5-3. An up-date on the epidemiology of major depressive disorder across cultures.